Cargando…
Using Graphene-Based Biosensors to Detect Dopamine for Efficient Parkinson’s Disease Diagnostics
Parkinson’s disease (PD) is a neurodegenerative disease in which the neurotransmitter dopamine (DA) depletes due to the progressive loss of nigrostriatal neurons. Therefore, DA measurement might be a useful diagnostic tool for targeting the early stages of PD, as well as helping to optimize DA repla...
Autores principales: | Kujawska, Małgorzata, Bhardwaj, Sheetal K., Mishra, Yogendra Kumar, Kaushik, Ajeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615362/ https://www.ncbi.nlm.nih.gov/pubmed/34821649 http://dx.doi.org/10.3390/bios11110433 |
Ejemplares similares
-
Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
por: Dubey, Ankit Kumar, et al.
Publicado: (2022) -
Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects
por: Oz, Tuba, et al.
Publicado: (2023) -
Biosensors for Epilepsy Management: State-of-Art and Future Aspects
por: Tiwari, Shivani, et al.
Publicado: (2019) -
Exploring magneto-electric nanoparticles (MENPs): a platform for implanted deep brain stimulation
por: Kujawska, Małgorzata, et al.
Publicado: (2022) -
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
por: Rahman, Mujeeb ur, et al.
Publicado: (2022)